Sukumar S - Search Results

1

Biomarker modulation following short-term vorinostat in women with newly diagnosed primary breast cancer.

Stearns V, Jacobs LK, Fackler M, Tsangaris TN, Rudek MA, Higgins M, Lange J, Cheng Z, Slater SA, Jeter SC, Powers P, Briest S, Chao C, Yoshizawa C, Sugar E, Espinoza-Delgado I, Sukumar S, Gabrielson E, Davidson NE. Stearns V, et al. Among authors: sukumar s. Clin Cancer Res. 2013 Jul 15;19(14):4008-16. doi: 10.1158/1078-0432.CCR-13-0033. Epub 2013 May 29. Clin Cancer Res. 2013. PMID: 23719261 Free PMC article. Clinical Trial.

2

Careful histological confirmation and microdissection reveal telomerase activity in otherwise telomerase-negative breast cancers.

Carey LA, Hedican CA, Henderson GS, Umbricht CB, Dome JS, Varon D, Sukumar S. Carey LA, et al. Among authors: sukumar s. Clin Cancer Res. 1998 Feb;4(2):435-40. Clin Cancer Res. 1998. PMID: 9516933

3

Absence of TSG101 transcript abnormalities in human cancers.

Trink B, Pai SI, Spunt SL, Raman V, Cairns P, Jen J, Gabrielson E, Sukumar S, Sidransky D. Trink B, et al. Among authors: sukumar s. Oncogene. 1998 May 28;16(21):2815-8. doi: 10.1038/sj.onc.1201795. Oncogene. 1998. PMID: 9652749

4

Altered WAF1 genes do not play a role in abnormal cell cycle regulation in breast cancers lacking p53 mutations.

McKenzie KE, Siva A, Maier S, Runnebaum IB, Seshadri R, Sukumar S. McKenzie KE, et al. Among authors: sukumar s. Clin Cancer Res. 1997 Sep;3(9):1669-73. Clin Cancer Res. 1997. PMID: 9815858

5

Telomerase activity and prognosis in primary breast cancers.

Carey LA, Kim NW, Goodman S, Marks J, Henderson G, Umbricht CB, Dome JS, Dooley W, Amshey SR, Sukumar S. Carey LA, et al. Among authors: sukumar s. J Clin Oncol. 1999 Oct;17(10):3075-81. doi: 10.1200/JCO.1999.17.10.3075. J Clin Oncol. 1999. PMID: 10506602

6

Wilms' tumor suppressor gene (WT1) is expressed in primary breast tumors despite tumor-specific promoter methylation.

Loeb DM, Evron E, Patel CB, Sharma PM, Niranjan B, Buluwela L, Weitzman SA, Korz D, Sukumar S. Loeb DM, et al. Among authors: sukumar s. Cancer Res. 2001 Feb 1;61(3):921-5. Cancer Res. 2001. PMID: 11221883

7

Loss of cyclin D2 expression in the majority of breast cancers is associated with promoter hypermethylation.

Evron E, Umbricht CB, Korz D, Raman V, Loeb DM, Niranjan B, Buluwela L, Weitzman SA, Marks J, Sukumar S. Evron E, et al. Among authors: sukumar s. Cancer Res. 2001 Mar 15;61(6):2782-7. Cancer Res. 2001. PMID: 11289162

8

Detection of breast cancer cells in ductal lavage fluid by methylation-specific PCR.

Evron E, Dooley WC, Umbricht CB, Rosenthal D, Sacchi N, Gabrielson E, Soito AB, Hung DT, Ljung B, Davidson NE, Sukumar S. Evron E, et al. Among authors: sukumar s. Lancet. 2001 Apr 28;357(9265):1335-6. doi: 10.1016/s0140-6736(00)04501-3. Lancet. 2001. PMID: 11343741

9

Hypermethylation of 14-3-3 sigma (stratifin) is an early event in breast cancer.

Umbricht CB, Evron E, Gabrielson E, Ferguson A, Marks J, Sukumar S. Umbricht CB, et al. Among authors: sukumar s. Oncogene. 2001 Jun 7;20(26):3348-53. doi: 10.1038/sj.onc.1204438. Oncogene. 2001. PMID: 11423985

10

DNA methylation of RASSF1A, HIN-1, RAR-beta, Cyclin D2 and Twist in in situ and invasive lobular breast carcinoma.

Fackler MJ, McVeigh M, Evron E, Garrett E, Mehrotra J, Polyak K, Sukumar S, Argani P. Fackler MJ, et al. Among authors: sukumar s. Int J Cancer. 2003 Dec 20;107(6):970-5. doi: 10.1002/ijc.11508. Int J Cancer. 2003. PMID: 14601057

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

549 results

Search Page

Filters